These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24655067)

  • 61. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
    Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
    Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Isolation and Characterization of Exosome from Human Embryonic Stem Cell-Derived C-Myc-Immortalized Mesenchymal Stem Cells.
    Lai RC; Yeo RW; Padmanabhan J; Choo A; de Kleijn DP; Lim SK
    Methods Mol Biol; 2016; 1416():477-94. PubMed ID: 27236691
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment.
    Manuguerra-Gagné R; Boulos PR; Ammar A; Leblond FA; Krosl G; Pichette V; Lesk MR; Roy DC
    Stem Cells; 2013 Jun; 31(6):1136-48. PubMed ID: 23495088
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current Progress in Treating Systemic Lupus Erythematosus Using Exosomes/MicroRNAs.
    Liu YJ; Miao HB; Lin S; Chen Z
    Cell Transplant; 2023; 32():9636897221148775. PubMed ID: 36661068
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
    Shin MJ; Park JY; Lee DH; Khang D
    Int J Nanomedicine; 2021; 16():8485-8507. PubMed ID: 35002240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
    Zhang H; Zeng X; Sun L
    Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases.
    Lou G; Chen Z; Zheng M; Liu Y
    Exp Mol Med; 2017 Jun; 49(6):e346. PubMed ID: 28620221
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.
    Tang WY; Liu JH; Peng CJ; Liao Y; Luo JS; Sun X; Tang YL; Luo XQ
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):7. PubMed ID: 33713197
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
    Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
    Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adult mesenchymal stem cells and their potency in the cell-based therapy.
    Das M; Sundell IB; Koka PS
    J Stem Cells; 2013; 8(1):1-16. PubMed ID: 24459809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exosomes for drug delivery - a novel application for the mesenchymal stem cell.
    Lai RC; Yeo RW; Tan KH; Lim SK
    Biotechnol Adv; 2013; 31(5):543-51. PubMed ID: 22959595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm.
    Yin K; Wang S; Zhao RC
    Biomark Res; 2019; 7():8. PubMed ID: 30992990
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases.
    Chen J; Li C; Chen L
    Biomed Res Int; 2015; 2015():985814. PubMed ID: 26064975
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.
    Vizoso FJ; Eiro N; Cid S; Schneider J; Perez-Fernandez R
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841158
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus.
    Xu L; Dai Q; Zhang Y; Lin N; Ji L; Song X
    Cell Transplant; 2024; 33():9636897241236586. PubMed ID: 38469823
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spheroid Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Microvesicles: Two Potential Therapeutic Strategies.
    Xie L; Mao M; Zhou L; Jiang B
    Stem Cells Dev; 2016 Feb; 25(3):203-13. PubMed ID: 26575103
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acquisition of new tumor cell properties by MSC-derived exosomes.
    Yang Y; Bucan V; Baehre H; von der Ohe J; Otte A; Hass R
    Int J Oncol; 2015 Jul; 47(1):244-52. PubMed ID: 25963929
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Therapeutic potential of human mesenchymal stromal cells secreted components: a problem with standartization].
    Sagaradze GD; Grigorieva OA; Efimenko AY; Chaplenko AA; Suslina SN; Sysoeva VY; Kalinina NI; Akopyan ZhA; Tkachuk VA
    Biomed Khim; 2015; 61(6):750-9. PubMed ID: 26716748
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus.
    Sharma J; Hampton JM; Valiente GR; Wada T; Steigelman H; Young MC; Spurbeck RR; Blazek AD; Bösh S; Jarjour WN; Young NA
    Front Immunol; 2017; 8():526. PubMed ID: 28539924
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A New Target of Dental Pulp-Derived Stem Cell-Based Therapy on Recipient Bone Marrow Niche in Systemic Lupus Erythematosus.
    Sonoda S; Yamaza T
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.